AKIRIN2
Gene Information
- Official Symbol: AKIRIN2
- Official Name: akirin 2
- Aliases and Previous Symbols: N/A
- Entrez ID: 55122
- UniProt: Q53H80
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Required for the innate immune response. Downstream effector of the Toll-like receptor (TLR), TNF and IL-1 beta signaling pathways leading to the production of IL-6. Forms a complex with YWHAB that acts to repress transcription of DUSP1 (By similarity). {ECO:0000250}.
Pfam Domains GO Terms
Pfam Domains
No Pfam Domain information is available for this gene.
GO Terms
| transcriptional repressor complex |
| positive regulation of interleukin-6 production |
| regulation of interleukin-6 production |
| positive regulation of endopeptidase activity |
| positive regulation of peptidase activity |
| response to lipopolysaccharide |
| response to molecule of bacterial origin |
| enzyme binding |
| positive regulation of proteolysis |
| regulation of endopeptidase activity |
| regulation of peptidase activity |
| positive regulation of cytokine production |
| embryo development ending in birth or egg hatching |
| response to bacterium |
| regulation of cytokine production |
| regulation of proteolysis |
| innate immune response |
| positive regulation of hydrolase activity |
| response to lipid |
| negative regulation of transcription by RNA polymerase II |
| positive regulation of cell population proliferation |
| defense response to other organism |
| embryo development |
| negative regulation of transcription, DNA-templated |
| positive regulation of transcription by RNA polymerase II |
| negative regulation of nucleic acid-templated transcription |
| negative regulation of RNA biosynthetic process |
| regulation of hydrolase activity |
| response to other organism |
| response to external biotic stimulus |
| response to biotic stimulus |
| negative regulation of RNA metabolic process |
| defense response |
| negative regulation of cellular macromolecule biosynthetic process |
| positive regulation of catalytic activity |
| negative regulation of nucleobase-containing compound metabolic process |
| negative regulation of macromolecule biosynthetic process |
| negative regulation of cellular biosynthetic process |
| positive regulation of transcription, DNA-templated |
| negative regulation of biosynthetic process |
| response to oxygen-containing compound |
| positive regulation of cellular protein metabolic process |
| regulation of cell population proliferation |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| positive regulation of protein metabolic process |
| negative regulation of gene expression |
| positive regulation of RNA metabolic process |
| positive regulation of multicellular organismal process |
| positive regulation of molecular function |
| immune response |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
| Screen | Score |
|---|---|
| CFI-400945 25μM R08 exp469 | -1.97 |
| Benzoate 20000μM R08 exp456 | -1.93 |
| TIC10 10μM R08 exp532 | -1.79 |
| UM131593 0.2μM R03 exp106 | -1.73 |
| 42°C R08 exp539 | -1.7 |
| D-Fructose 10000μM R06 exp279 | 1.82 |
| Metformin 100 to 150μM on day4 R04 exp170 | 1.86 |
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| TCEB3CL2 | 0.553 |
| POLR2J3 | 0.55 |
| TFIP11 | 0.548 |
| KCTD17 | 0.544 |
| LRR1 | 0.533 |
| NDC1 | 0.527 |
| TCEB3C | 0.525 |
| RBBP5 | 0.521 |
| C14orf93 | 0.517 |
| TCEB3CL | 0.513 |
| C1QTNF9B | 0.508 |
| PSMA6 | 0.508 |
| SF3A3 | 0.503 |
| NUPL1 | 0.502 |
| DTL | 0.491 |
| ORC6 | 0.49 |
| TBC1D3G | 0.49 |
| RPS28 | 0.488 |
| VASN | 0.488 |
| TBC1D3H | 0.485 |
| NBPF10 | 0.484 |
| MED17 | 0.484 |
| ORC1 | 0.483 |
| PSMD1 | 0.483 |
| COPA | 0.483 |
| RPS12 | 0.478 |
| IK | 0.477 |
| NUP54 | 0.476 |
| HAP1 | 0.475 |
| RBM39 | 0.475 |
| CDCA3 | 0.475 |
| CDC73 | 0.474 |
| UBAP1 | 0.474 |
| DDTL | 0.473 |
| CCDC94 | 0.471 |
| DNTTIP2 | 0.47 |
| GOLGA6A | 0.47 |
| PSMB1 | 0.47 |
| RPSA | 0.469 |
| VPS54 | 0.467 |
| TBC1D3C | 0.467 |
| PPFIA4 | 0.466 |
| MYO18A | 0.466 |
| ISCU | 0.466 |
| PSMB4 | 0.465 |
| RANBP2 | 0.465 |
| RPL14 | 0.464 |
| SLC4A1 | 0.463 |
| ZFAND5 | 0.462 |
| NPIPB5 | 0.462 |
| RFFL | 0.461 |
| WDR87 | 0.46 |
| SNRNP70 | 0.459 |
| COPZ1 | 0.459 |
| PLA2G4F | 0.458 |
| TBC1D3F | 0.456 |
| TBC1D3K | 0.455 |
| TBC1D3L | 0.455 |
| TBC1D3E | 0.455 |
| TBC1D3I | 0.455 |
| NUP43 | 0.454 |
| WDR75 | 0.453 |
| EXOSC5 | 0.453 |
| ACD | 0.453 |
| TWISTNB | 0.452 |
| MYT1L | 0.452 |
| MYO1H | 0.45 |
| ANKLE2 | 0.45 |
| HMGCR | 0.449 |
| TBC1D3 | 0.449 |
| RPS2 | 0.448 |
| PSMD14 | 0.448 |
| RPS14 | 0.448 |
| POLR2F | 0.446 |
| PLK4 | 0.446 |
| PSMD11 | 0.446 |
| NUFIP2 | 0.446 |
| POLR1A | 0.445 |
| ZNF106 | 0.445 |
| SEC13 | 0.445 |
| AAAS | 0.445 |
| AHCTF1 | 0.444 |
| MADCAM1 | 0.444 |
| OGFR | 0.442 |
| CHD4 | 0.442 |
| UTP20 | 0.442 |
| PSMC2 | 0.442 |
| CLN6 | 0.442 |
| ANKLE1 | 0.441 |
| NUP153 | 0.441 |
| CACTIN | 0.439 |
| GOLGA6L3 | 0.439 |
| RFXANK | 0.438 |
| SYT9 | 0.438 |
| TICRR | 0.438 |
| INTS6 | 0.438 |
| S1PR4 | 0.438 |
| SUPT6H | 0.437 |
| NSF | 0.437 |
| NARFL | 0.437 |
| CDC45 | 0.436 |
| GID4 | 0.435 |
| PSMC1 | 0.434 |
| PSMB2 | 0.434 |
| COPG1 | 0.433 |
| SMG7 | 0.433 |
| CTR9 | 0.432 |
| PDE4DIP | 0.432 |
| ESF1 | 0.43 |
| TIMELESS | 0.43 |
| OR10G3 | 0.43 |
| COPE | 0.43 |
| SNIP1 | 0.428 |
| GNB3 | 0.428 |
| ZNF830 | 0.427 |
| ARCN1 | 0.427 |
| SF3A1 | 0.427 |
| NFATC4 | 0.427 |
| COL2A1 | 0.427 |
| SMG1 | 0.426 |
| ACBD4 | 0.426 |
| CDK12 | 0.426 |
| INTS5 | 0.425 |
| POLA2 | 0.424 |
| NOP16 | 0.424 |
| LIPE | 0.424 |
| SLC6A17 | 0.424 |
| SCAF1 | 0.424 |
| AAMP | 0.423 |
| PSMC6 | 0.423 |
| CASC3 | 0.423 |
| APC2 | 0.422 |
| RPL6 | 0.422 |
| GOLGA6L4 | 0.422 |
| NBPF16 | 0.421 |
| ELMOD3 | 0.421 |
| MED14 | 0.421 |
| GGA3 | 0.42 |
| MT1E | 0.42 |
| MYLK3 | 0.419 |
| TOP1MT | 0.419 |
| HIST1H2BE | 0.418 |
| PSMD3 | 0.418 |
| TAF1 | 0.417 |
| KIF3C | 0.416 |
| RRN3 | 0.416 |
| KPNB1 | 0.415 |
| TERF2 | 0.415 |
| NUP205 | 0.415 |
| DHX38 | 0.414 |
| RPS19 | 0.414 |
| ADRA1D | 0.414 |
| GOLGA6L6 | 0.414 |
| RPL35 | 0.414 |
| PWP2 | 0.413 |
| CBWD5 | 0.413 |
| TP53TG3B | 0.412 |
| ATP6V1C1 | 0.412 |
| ATXN1 | 0.412 |
| TP53TG3C | 0.411 |
| TP53TG3 | 0.411 |
| AQR | 0.411 |
| POLE | 0.411 |
| KIAA0947 | 0.411 |
| CBWD3 | 0.411 |
| TERF1 | 0.411 |
| APRT | 0.41 |
| RAN | 0.41 |
| CDC6 | 0.41 |
| RNF113A | 0.41 |
| C2orf27B | 0.41 |
| TSPY8 | 0.41 |
| MDM2 | 0.409 |
| SEL1L | 0.409 |
| BYSL | 0.409 |
| NUP62 | 0.408 |
| NAPA | 0.408 |
| RPS7 | 0.407 |
| UTP3 | 0.407 |
| CHMP4B | 0.407 |
| OTOF | 0.407 |
| SH3BP1 | 0.406 |
| ACSF2 | 0.405 |
| DNM2 | 0.405 |
| ZNF219 | 0.405 |
| RAD51 | 0.404 |
| GAR1 | 0.404 |
| PCF11 | 0.404 |
| TRAIP | 0.403 |
| PSAP | 0.403 |
| EXOSC6 | 0.402 |
| PRPF3 | 0.401 |
| XYLT2 | 0.401 |
| GRAMD1A | 0.4 |
| OSBP | 0.4 |
| INTS1 | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 232/726
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 1/1 |
| bile duct | 10/28 |
| blood | 11/28 |
| bone | 8/25 |
| breast | 12/33 |
| central nervous system | 14/56 |
| cervix | 1/4 |
| colorectal | 4/17 |
| esophagus | 3/13 |
| fibroblast | 1/1 |
| gastric | 5/15 |
| kidney | 4/21 |
| liver | 8/20 |
| lung | 20/75 |
| lymphocyte | 7/14 |
| ovary | 5/26 |
| pancreas | 5/24 |
| peripheral nervous system | 4/16 |
| plasma cell | 12/15 |
| prostate | 1/1 |
| skin | 12/24 |
| soft tissue | 2/7 |
| thyroid | 0/2 |
| upper aerodigestive | 8/22 |
| urinary tract | 12/29 |
| uterus | 1/5 |
Essentiality in NALM6
- Essentiality Rank: 1590
- Expression level (log2 read counts): 5.08
Expression Distribution
AKIRIN2 Expression in NALM6 Cells: 5.08